Publication: Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders
No Thumbnail Available
Date
2018-12-01T00:00:00Z
Authors
Authors
Kocaman, Gulsen
Kahraman, Nese
Gurkan Koseoglu, Banu
Bilgic, Basar
Ertas, Mustafa
Gulsen, Yesim
Baykan Baykal, Betul
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Abstract
Introduction: Migraine and temporomandibular disorders (TMD) are both common diseases and TMD are reported as a risk factor in migraine progression. OnabotulinumtoxinA is used in the treatment of chronic migraine (CM), and also has a potential role in TMD treatment. In this study, it is aimed to compare the efficacy of onabotulinumtoxinA treatment in CM patients with and without TMD.
Description
Keywords
Citation
Kocaman G., Kahraman N., Gurkan Koseoglu B., Bilgic B., Matur Z., Ertas M., Gulsen Y., Baykan Baykal B., -Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders-, NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, cilt.55, ss.330-336, 2018